Literature DB >> 1874943

Microsurgical fertilization and teratozoospermia.

J Cohen1, B E Talansky, H Malter, M Alikani, A Adler, A Reing, A Berkeley, M Graf, O Davis, H Liu.   

Abstract

Semen parameters were correlated with the outcome of partial zona dissection (PZD) in 42 couples with male factor infertility. Although fertilization rates were reduced, 12% of the embryos implanted following replacement. Spermatozoa from teratozoospermic sperm populations were able to fuse with oocytes following zona penetration through the artificial gaps. PZD followed by insemination with less than 5% normal spermatozoa led to 20 embryos which, upon replacement, did not implant. Motility and sperm count were not clearly correlated with the outcome of PZD and are therefore less useful indicators for patient selection. Teratozoospermic patients who previously failed to fertilize were compared to a group of similar patients who had not attempted IVF before. Although fertilization was significantly improved in first-time patients, 41% of the patients whose spermatozoa were initially unable to fertilize had at least one embryo when PZD was performed. Several pregnancies were established in this group. Subzonal sperm insertion (SZI) and PZD were compared in 19 patients using sibling oocytes. A significant fraction of spermatozoa from infertile men were able to fuse with the oolemma when directly inserted into the perivitelline area. Using a sucrose solution to shrink the ooplasm, only 1% of the oocytes were damaged during SZI. Monospermic fertilization rates following PZD and SZI were 15 and 16%, respectively. Both micromanipulation methods were successful in most patients. However, in two small groups of patients, only one technique resulted in fertilization.

Entities:  

Mesh:

Year:  1991        PMID: 1874943     DOI: 10.1093/oxfordjournals.humrep.a137244

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Intracytoplasmic sperm injection increases embryo fragmentation without affecting clinical outcome.

Authors:  J L Frattarelli; M P Leondires; B T Miller; J H Segars
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

2.  Controversies in micro-injection.

Authors:  S C Ng; T A Bongso; S L Liow; R Edirisinghe; V Tok; S S Ratnam
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

3.  Abnormal sperm morphology is highly predictive of pregnancy outcome during controlled ovarian hyperstimulation and intrauterine insemination.

Authors:  S R Lindheim; D H Barad; M Zinger; B Witt; H Amin; B Cohen; H Fisch; P Barg
Journal:  J Assist Reprod Genet       Date:  1996-08       Impact factor: 3.412

4.  Subzonal insemination (SUZI) or in vitro fertilization (IVF) in microdroplets for the treatment of male-factor infertility.

Authors:  P Svalander; M Wikland; A H Jakobsson; A S Forsberg
Journal:  J Assist Reprod Genet       Date:  1994-03       Impact factor: 3.412

5.  A new rapid method of producing microneedles for subzonal sperm insertion.

Authors:  J W Gordon; C H Lih; D Navot; B S Zetner; N Laufer
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412

6.  Microsurgical fertilization procedures: the absence of stringent criteria for patient selection.

Authors:  J Cohen; M Alikani; A Adler; A Berkeley; O Davis; T A Ferrara; M Graf; J Grifo; H C Liu; H E Malter
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

7.  A randomized study of intracytoplasmic sperm injection (ICSI) versus subzonal insemination (SUZI) for the management of severe male-factor infertility.

Authors:  D Levran; D Bider; M Yonesh; Z Yemini; D S Seidman; S Mashiach; J Dor
Journal:  J Assist Reprod Genet       Date:  1995-05       Impact factor: 3.412

8.  Human sperm chromosome analysis after microinjection into hamster oocytes.

Authors:  J Cozzi; E Chevret; S Rousseaux; R Pelletier; B Sèle
Journal:  J Assist Reprod Genet       Date:  1995-07       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.